Navigation Links
Microbiology in Medical Technology

Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743

... systems and assays designed to streamline microbiology testing and improve health outcomes for patients at the 108th meeting of the American Society for microbiology (ASM). Magellan subsidiaries, TREK Diagnostic ... and CEO, Robert J. Rosenthal, Ph.D. "Managers of microbiology labs are looking for integrated systems that ...

Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program

... of GeoVax Labs, Inc. She served as Chief of microbiology and Immunology at Emory University's Yerkes ... Center and was an Asa Griggs Candler Professor of microbiology and Immunology at the Emory University School of ... from Swarthmore College and earned her PhD in microbiology from the Massachusetts Institute of Technology. ...

Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia

... said Dr. Donald Low, Head of the Division of microbiology in the Department of Laboratory Medicine and ... by Donald E. Low, M.D., a recognized authority in microbiology and infectious diseases. The conference call ... of Manitoba and his training in Medical microbiology at the University of Toronto. He is a Fellow of ...

CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas

... University of Hawaii reported on data at the annual American Society for microbiology in Philadelphia, PA. This data demonstrates that vaccines utilizing its ... as well. Dr. Borthakur, of the University of Hawaii , reported at the microbiology Conference that mouse blood cells taken from L.E.A.P.S. TB immunized mice ...

Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection

... subgroup analysis presented at 19th annual European Congress of Clinical microbiology and Infectious Diseases (ECCMID) meeting in Helsinki , Finland ... in an oral presentation at the 19th annual European Congress of Clinical microbiology and Infectious Diseases (ECCMID) in Helsinki, Finland. (Logo: ...

Study Shows Use of AdvanDx's PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections

... necessary for other nucleic acid technologies. PNA FISH tests enable microbiology labs to provide rapid and accurate identification of bloodstream pathogens ... of translation of PNA FSH-generated laboratory data from the clinical microbiology bench to bedside in real time. Therapeutics and Clinical Risk Management ...

BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures

... It is easy to perform and requires less technologist time than traditional microbiology algorithms, which can take two days to generate results. Studies have shown that providing physicians with critical microbiology information earlier will result in decreased mortality, length of stay and ...

Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy

... through an unrestricted educational grant to the American Society for microbiology and Conexus Health. Symposium and Presentation Schedule Monday, ... Chronic Hepatic Insufficiency About ICAAC The American Society for microbiology (ASM) is hosting the 47th Interscience Conference on Antimicrobial Agents ...

Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced

... its efforts: one in Japan (Yakult Central Institute for Microbiological Research) and one in Europe (Yakult Honsha European Research Center for microbiology ESV). Since developing its overseas network in 1964, Yakult has expanded its business to 32 countries and regions. In addition to producing the ...

IBM and EU Partners Create a Better Way to Fight AIDS Virus

... oriented antiretroviral drug resistance database in the world," explained Professor Maurizio Zazzi, EuResist Scientific Coordinator and Professor of microbiology at the University of Siena School of Medicine." The ability to analyze clinical, laboratory and demographic data accumulated over the years ...

BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results

... to help patients who may have difficulty with an oral or inhaled anti-viral medication. In addition, BioCryst is in negotiations with the Division of microbiology and Infectious Diseases (DMID) and the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) to ...

Corgenix, Tulane Announce Award of NIH Grant Extending Hemorrhagic Fever Virus Product Development Program

... potential bioterrorism agents due to their high fatality rate and ease of transmission from person-to-person. Robert Garry, Ph.D., Professor of microbiology and Immunology at the Tulane University School of Medicine and Principle Investigator of the program, added, "We have been very pleased with the ...

Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System Have Begun

... deaths and serious infections currently plaguing the healthcare system world wide. Dr. Dick Zoutman, an internationally recognized expert in Medical microbiology and hospital infections, is leading these trials. Medizone International's Director of Medical Affairs, Dr. Michael E. Shannon observed, "This is an ...

Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases

... its lead program, torezolid (TR-701), will be presented in an oral session and six poster presentations at the 19th European Congress of Clinical microbiology and Infectious Diseases (ECCMID) meeting in Helsinki, Finland May 16-19. Torezolid is a novel antibiotic that recently completed Phase 2 clinical ...

New Study Shows Probiotic Strain Effective in Boosting Immune Response to Flu Virus

... comprises approximately 70 percent of the body's immune system, a hypothesis supported by the current study. Dr. Gary Huffnagle, a professor of microbiology and immunology at the University of Michigan , who has reviewed the study's findings, said, "Today, people take medicine to achieve symptomatic ...

AdvanDx Launches Fast, 90 Minutes Protocol for All CE-IVD Marked PNA FISH(R) Tests in Europe

... Cost/Benefit and outcomes studies proving clinical utility of faster results About PNA FISH (R) PNA FISH tests enable microbiology labs to provide rapid and accurate identification of bloodstream pathogens directly from positive blood cultures in hours instead of days. Clinical ...

Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009

... integrated research strategy, which combines state-of-the-art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments

... toward moving our research further at a more rapid pace." Dr. Kachlany, founder of Actinobac Biomed and an associate professor of oral biology, microbiology and molecular genetics at UMDNJ-New Jersey Dental School, discovered the agent, Leukotoxin, during the course of his research at the dental school. ...

Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile

... 3. European Centre for Disease Prevention and Control, Emergence of Clostridium difficile-associated disease in North America and Europe, Clinical microbiology and Infectious Diseases, 2006; 12 (Suppl. 6): 2-18 4. HPA: ...

Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program

... in whole or in part with Federal (United States Government) funds from the National Institute of Allergy and Infectious Diseases (NIAID), Division of microbiology and Infectious Diseases (DMID), under contract number HHSN272200800024C. Pursuant to section 507 of P.L. 104-208 and Section 508 of P.L. 105-78, 100% ...

Delcath Adds Dr. Pamela R. Contag to Its Board of Directors

... Dr. Contag was also recognized as one of the "Top 25 Women in Small Business" by Fortune magazine. Dr. Contag received her Ph.D. in microbiology from the University of Minnesota Medical School and completed her postdoctoral training at Stanford University School of Medicine. Dr. Contag is ...

Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin

... integrated research strategy, which combines state-of-the-art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

Parasites That Live Inside Cells Use Loophole to Thwart Immune System

... Md.); Marcela Henao-Tamayo, Randall Basaraba and Ian Orme (Colorado State University, Fort Collins, Co.); Till Konig (Institute of Medical microbiology and Hygiene University Clinic of Freiburg, Germany); Ulrike Schleicher and Christian Bogdan (Immunology and Hygiene University Clinic of Erlangen, ...

Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting

... integrated research strategy, which combines state-of-the-art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA

... Targeting Methionyl-tRNA Synthase (MetRS) -- F1-335: In Vitro Activity of Rx100472 Against Clinically Important Bacteria -- F1-336: Advanced microbiology Study of Rx100472, A Novel Methionyl-tRNA Synthetase (MetRS) inhibitor -- F1-337: In Vivo Efficacy of Rx100472, A Novel Methionyl-tRNA ...

Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu

... be right up there, but this survey shows us that we still have a lot of educating to do," said Anne Moscona, M.D., professor of pediatrics and of microbiology and immunology, and vice chair of pediatrics for research at Weill Medical College of Cornell University. "As a community, we need to do a better job ...

Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences

... integrated research strategy, which combines state of the art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections

... integrated research strategy, which combines state of the art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

Advaxis, Inc Initiation Coverage Review Issued By Scimitar Equity, LLC

... Inc is developing proprietary Listeria monocytogenes ("Lm") cancer vaccines based on technology developed by Dr. Yvonne Paterson, Professor of microbiology at the University of Pennsylvania and Chairperson of Advaxis' Scientific Advisory Board. Advaxis is developing therapeutic cancer vaccines ...

'Snapshots' of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report

... that cell death has occurred and tissue is beginning to break down," says Petty, professor of Ophthalmology and Visual Sciences, and professor of microbiology and Immunology at the U-M Medical School. "FA serves as a 'spectral-biomarker' for metabolism gone awry, and we can use the results to detect and ...

Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections

... Chemotherapy (2004) 53, Suppl. S2, ii37-ii50. 2. R. Finch (2006) Gram-positive infections: lessons learnt and novel solutions Clinical microbiology and Infection 12 (s8) , 3-8 doi:10.1111/j.1469-0691.2006 3. Su Young Lee, Joseph L. Kuti, David P. Nicolau. Surgical Infections. September ...

AdvanDx Submits Yeast Traffic Light PNA FISH(TM) for FDA 510(k) Clearance for Detection of Candida species in Positive Blood Cultures

... (FISH) assay that uses PNA (peptide nucleic acid) probes to target species specific ribosomal RNA (rRNA) in bacteria and yeast. PNA FISH tests enable microbiology labs to provide rapid and accurate identification of bloodstream pathogens directly from positive blood cultures in hours instead of days. Clinical ...

Amikacin Inhale Shows Promising Results in Phase II Study

... in ICUs is that they have grown increasingly resistant to currently available antibiotics," said Professor Donald Low, Head of the Department of microbiology at the Toronto Medical Laboratories and Mount Sinai Hospital, Toronto, Canada. "A new treatment option such as Amikacin Inhale, which fights ...

Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas

... Health, including National Cancer Institute. The three senior immunobiologists, Drs. Joseph Coggin, Jim Rohrer and Adel Barsoum of the Department of microbiology and Immunology at the University of South Alabama, will collaborate with the primary investigator, Dr. Paul Schwartzenberger, M.D., an SCC ....

Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council

... integrated research strategy, which combines state of the art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

Arpida Provides Further Comments on the Pivotal Phase III Trials

... has been presented at last year's ICAAC and IDSA meetings. Data on ASSIST-2 will be presented at the upcoming 18th European Congress of Clinical microbiology and Infectious Diseases (ECCMID) which takes place in Barcelona, 19-22 April 2008. As reported in November 2006 and July 2007, intravenous ...

Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference

... integrated research strategy, which combines state of the art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases

... SAI ) today announced that it was awarded a contract extension by the National Institute of Allergy and Infectious Diseases' (NIAID) Division of microbiology and Infectious Diseases (DMID), part of the National Institutes of Health, to provide malaria vaccine production and support services. The ...

Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control

... computer keyboard and survive as long as 24 hours. Viruses can live on them for one hour or more." A study reported at the American Society for microbiology found that MRSA can survive on computer keyboards for up to 6 weeks. The recent rise in hospital acquired infections, and the lack of an effective ...

Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV

... represents a milestone in treatment for this disease," said Mark Wainberg, MD, director of the McGill AIDS Centre and professor of medicine and microbiology at McGill University. "I commend the companies involved for joining forces to make ATRIPLA, the first complete three-drug regimen in a single ...
Other Contents
(Date:11/21/2014)... 18, 2014 According to a ... Systems (Video, RFID, Access Control, Intrusion Detection, Parking Management, ... Government), Component Service Geography - Global Forecasts to 2020", ... projected to be around $25 Billion in 2014 and ... at a CAGR of 8.69%. Browse 116 ...
(Date:11/21/2014)... Nov. 20, 2014 C-Labs LLC, a leading ... of Things (IoT), today announced the appointment of ... officer. Previously a strategic advisor to the firm, Mr. ... Mr. Traynor is based out of the C-Labs office ... to Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)...   News Highlights: ... The Partners Data Lake, an agile data and ... will allow researcher and clinicians to explore and ... lives of patients , The Partners Data ... the Partners system, breaking down physical barriers for ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
(Date:12/19/2014)... Steven Reinberg HealthDay ... If you can,t balance on one leg for at least ... Japanese researchers suggest. Difficulty standing on one leg may ... which means the risk for more serious strokes is high, ... Stroke . "Individuals showing instability while standing on one ...
(Date:12/17/2014)... Myo Nwe is the co-author of a new weight loss ... of the Ace Medical Weight Loss Center in Rock Hill, ... at the industry of weight loss, and how several fad ... in television shows, however, she says the topic of obesity ... for basic laughs, which she believes impacts whether Americans view ...
(Date:12/17/2014)... This prestigious award is given annually ... outstanding and innovative contributions to the physical therapy ... practice physical therapy by the Private Practice Section ... behalf of Performance Physical Therapy, Michelle Collie PT, ... accepted the award at the Private Practice, APTA ...
(Date:12/17/2014)... 2014 A group of 127 scientists sent ... in reaction to a recent statement by the center that ... and derogated the efficacy of all brain exercises. , Signatories ... parts of the center’s statement critical of brain exercise companies ... also overstated its case, in a document it had entitled ...
(Date:12/17/2014)... No matter how far modern medicine ... the head louse parasite—a common childhood malady and a ... between six and twelve million individuals will suffer an ... treatment company comes to the rescue, providing an all-natural ... its track record of customer service, and effectiveness in ...
Breaking Medicine News(10 mins):Health News:Can You Balance on One Leg? You May Have Lower Stroke Risk 2Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2
Other TagsOther Tags